Telomeric Repeat Containing RNA (TERRA): Aging and Cancer

Author(s): Sonam Sinha, Samriddhi Shukla, Sajid Khan, Mohammad Farhan, Mohammad Amjad Kamal, Syed Musthapa Meeran.

Journal Name: CNS & Neurological Disorders - Drug Targets

Volume 14 , Issue 7 , 2015

Submit Manuscript
Submit Proposal

Abstract:

Telomeric repeat containing RNAs (TERRA) are small RNA molecules synthesized from telomeric regions which were previously considered as silent genomic domains. In normal cells, these RNAs are transcribed in a direction from subtelomeric region towards the chromosome ends, but in case of cancer cells, their expression remains limited or absent. Telomerase is a rate limiting enzyme for cellular senescence, cancer and aging. Most of the studies deal with the manipulation of telomerase enzyme in cancer and aging either by synthetic oligonucleotide or by natural phytochemicals. Here, we collected evidences and discussed intensely about the bio-molecular structure of TERRA, naturally occurring ligands of telomerase, and their genetic and epigenetic regulations in aging associated diseases. Due to their capability to act as naturally occurring ligands of telomerase, these RNAs can overcome the limitations possessed by synthetic oligonucleotides, which are aimed against telomerase. Drugs specifically targeting TERRA molecules could modulate telomerase-mediated telomere lengthening. Thus, targeting TERRA-mediated regulation of telomerase would be a promising therapeutic strategy against cancer and age-associated diseases.

Keywords: Aging, cancer, non-coding RNA, telomerase, telomere.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 14
ISSUE: 7
Year: 2015
Page: [936 - 946]
Pages: 11
DOI: 10.2174/1871527314666150317230124
Price: $58

Article Metrics

PDF: 40
HTML: 1